PATENT CLAIM ANALYSIS

Application Number: 16172888
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "183000"]

Abstract:
The present invention relates to use of antipsychotic phenothiazine derivative for treatment of cancer. The invention also provides a use for manufacture a medicament, a pharmaceutical composition and a method for treating a cancer, and/or preventing or delaying cancer recurrence based on trifluoperazine. The invention further provides a use for manufacture a medicament, a pharmaceutical composition and a method for treating cancer based on thioridazine and its enantiomers. Additionally, the invention provides a use for manufacture a medicament, a pharmaceutical composition and a method for treating KRAS mutant NSCLC comprising thioridazine.

Claim (Index 12):
A method for treating cancer in a subject, comprising administering to the subject in need a therapeutically effective amount of a pharmaceutical composition comprising (S)-thioridazine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier wherein the pharmaceutical composition is substantially free of (R)-thioridazine.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 2.32558
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15337293', '14058066', '14990651', '14505288', '13837115']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.762312097966969
- 35 USC 102 Novelty (BERT): 0.5144017238732889
- Combined Prediction Score: 0.737521060557601
- Mean Citation Score: 279.584622
- Max Citation Score: 299.63898
- Similarity Product: 213.6422532594967

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test